plasma care® celebrates product launch in Taiwan
plasma care receives market approval from the TFDA in Taiwan and is now exclusively distributed by Omega Medical in Taiwan.
Herr Herbert (2.v.links) konnte Herrn Kirsch (2.v.rechts) und das Team der terraplasma medical bereits erfolgreich auf dem Europäischen Wundmanagement Kongress (EWMA) in London unterstützen.
Expansion of the management of terraplasma medical GmbH
As Managing Director, Lukas Herbert will work with Jens Kirsch to drive forward the expansion and internationalization of the company.
Cold plasma conquers Brazil: terraplasma medical announces market approval and launch of plasma care®
terraplasma medical announces marketing authorisation and market launch of plasma care® in Brazil.
Internationalization: terraplasma medical on expansion course with mobile cold plasma device plasma care®.
The international expansion of terraplasma medical GmbH, a subsidiary of the Viromed Group, is progressing. The strategic mainstay is the innovative treatment of wounds based on cold atmospheric plasma (KAP). The focus is on the mobile, CE-certified cold plasma device plasma care®, which closes wounds painlessly and inactivates viruses, fungi and bacteria.
Successful trade show – EADV opens up new markets for plasma care®
With over 600 speakers and almost 16,000 participants, the annual EADV congress is Europe's most important event in the field of dermatology and venereology. From October 11 to 14, we…
Study proves: Cold plasma is a quantum leap for the treatment of chronic wounds
There is a solution for people with chronic and non-healing wounds: cold atmospheric plasma (KAP). As a pilot study commissioned by Munich-based terraplasma medical GmbH, a company of the Hamburg-based Viromed Group, proves, the innovative wound and skin treatment of the cold plasma technique is superior to standard wound treatment (SWT).
The future of wound therapy: testing of medical cold plasma brings new hope for patients with chronic wounds
The three leading companies neoplas med GmbH, terraplasma-medical GmbH and Cinogy System GmbH are forming a consortium to commission the trial study in the method evaluation procedure of the Federal Joint Committee (G-BA).
An exclusive sales cooperation agreement between terraplasma medical GmbH and GD Medical has been signed.
GD Medical becomes exclusive distributor for the benelux region.
Strong distribution partner for the GCC countries
Press release Garching July 10th, 2023 Cold plasma therapy will revolutionize therapy for chronic wound patients in GCC countries. Today the exclusive distribution cooperation between terraplasma medical and BSM Binary…
Gemeinsamer Bundesausschuss (G-BA)
Wound treatment with cold plasma clears the main hurdle on the way to reimbursement by the statutory health insurance funds
The next step towards reimbursement for cold plasma therapy has been achieved. The Federal Joint Committee decides to conduct a trial study.